DirectorChing-Yeh Lin
Professional license
- 2002 Medical Practitioner’s License, R.O.C.
- 2007 Specialist, Board of Internal Medicine, R.O.C.
- 2009 Specialist, the Board of Hematology, Hematology Society of Taiwan
- 2010 Specialist, the Board of Medical Oncology, Chinese Oncology Society
Educational qualifications
- Department of Medicine,Yang-Ming Medical University
- 2004 MAY-2007 JUL Resident,Department of intermalmedicine,VGHTC
- 2007 AUG -2010 NOV Chief Resident, Department of Hematology/Oncology,VGHTC
- 2010 DEC -2010 DEC Attending Physician,Department of Hematology/Oncology, VGHTC
- 2010 DEC-2022 OCT Attending physician, Department of Hematology/Oncology,CCH
- 2024JAN – present Chief,Department of Hematology/Oncology, Wuri Lin Shin Hospital
- Coagulation
- venous thromboembolism disorders
- Hesperetin Induces Autophagy and Delayed Apoptosis by Modulating the AMPK/Akt/mTOR Pathway in Human Leukemia Cells In Vitro,Ching-Yeh Lin , Ya-Hui Chen , Ying-Chih HuangCurr Issues Mol Biol. 2023 Feb 13;45(2):1587-1600.
- Arctigenin Reduces Myofibroblast Activities in Oral Submucous Fibrosis by LINC00974 Inhibition, Ching-Yeh Lin, Pei-Ling Hsieh, Yi-Wen Liao, Chih-Yu Peng, Cheng-Chia Yu, Ming-Yi Lu, International Journal of Molecular Sciences. 2019, 20, 1328
- Association and risk factors of chronic kidney disease and incident diabetes: a nationwide population-based cohort study, Ching-Yeh Lin, Ming-Chia Hsieh1, Chew-Teng Kor1, Yao-Peng Hsieh, Diabetologia (2019) 62:438–447
- Immune thrombocytopenic pupura-induced reversible posterior leukoencephalopathy successfully treated by rituximab, Ching-Yeh Lin, Hung-Chieh Chen, Wen-Lee